Opioid Maker to Pay for Overdose Antidote Development

Share this content:
Opioid Maker to Pay for Overdose Antidote Development
Opioid Maker to Pay for Overdose Antidote Development

THURSDAY, Sept. 6, 2018 (HealthDay News) -- A $3.4 million grant to help a non-profit company develop a less expensive opioid overdose antidote was announced by Purdue Pharma, which makes the opioid painkiller OxyContin.

The grant is being given to Pittsburgh-based Harm Reduction Therapeutics, which is trying to develop a low-cost nasal spray with the opioid overdose antidote naloxone.

Purdue is among a number of prescription opioid makers blamed for causing the United States' opioid addiction and overdose crisis, the Associated Press reported.

Purdue and other drug companies are being sued by local governments that claim the companies used deceptive marketing that encouraged doctors to overprescribe opioids, the AP reported. As of last week, opioid makers faced more than 1,000 lawsuits being overseen by a federal judge.

AP News Article
Purdue Pharma News Release

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: More Cases in Salmonella Outbreak Linked to Recalled Beef

CDC: More Cases in <i>Salmonella</i> Outbreak Linked to ...

Three more states have reported illnesses; 87 new cases include 32 people who have been hospitalized

Eligibility Criteria Limit Access to Arthroplasty for Minorities

Eligibility Criteria Limit Access to Arthroplasty for Minorities

Those with lower socioeconomic status, lower education level have reduced odds of being eligible

is free, fast, and customized just for you!




Already a member?

Sign In Now »